Evidence shows that most patients with IBS would give up 20% of their lifespan for one symptom-free year. Pairing this data with real patient experiences highlights the need for care that addresses both physical and emotional symptoms, making symptom relief a true measure of success.
IBS may not be visible, but its burden is constant. CBT offers practical ways to manage symptoms and improve quality of life, yet most patients never hear about it. Expanding access can help people live with greater comfort and confidence.
For people with celiac disease, fiber alone may not heal the gut. McMaster research shows the right gut bacteria, like Prevotellaceae, are needed to process fiber. Supporting gut health may require combining diet with microbiome-focused strategies, not just gluten avoidance.
Patients with GI conditions often need more than medication to manage their complex conditions. Integrated care with GI dietitians allows personalized nutrition support, improves outcomes, and helps gastroenterologists focus on complex medical management.
1 in 5 adults face GI conditions, yet care is often fragmented. Integrated virtual GI solutions can help patients manage symptoms, improve quality of life, and reduce unnecessary ER visits, all while supporting PCPs in delivering holistic care.
The Celiac Disease Foundation’s $15M Impact Fund is redefining philanthropy by investing in detection, education, prevention, and therapies. With most cases undiagnosed and research underfunded, this patient-focused, venture-driven approach aims to accelerate solutions that are sustainable.
“Compassion is a commitment,” as Brené Brown says. In gastroenterology, that choice shapes care every day. For patients with IBS, IBD, or celiac disease, feeling heard and supported drives trust and ultimately better outcomes.
“Compassion is a commitment,” as Brené Brown says. In gastroenterology, that choice shapes care every day. For patients with IBS, IBD, or celiac disease, feeling heard and supported drives trust and ultimately better outcomes.
AI in IBD generates massive data from endoscopy, histology, and wearable, but data alone doesn’t improve care. Its value comes when insights are actionable, integrated into workflows, and support clinicians in delivering the right treatment to the right patient at the right time.
Patient empowerment, in practice, doesn't end at providing more information. We must also create a clinical environment where questions are expected, and patients feel confident participating in decisions that affect their health.
Research has consistently shown that when patients understand their diagnosis and expected outcomes, adherence improves and decision-making becomes far more collaborative. Yet that level of understanding often depends on whether patients feel comfortable engaging in the conversation.
What are the alternatives to this treatment? What side effects should I realistically expect? How will this affect my daily life? What happens if we wait?
In many clinical settings, patients hesitate to speak up. Some worry about appearing confrontational, and others feel constrained by short appointment times or assume the clinician’s recommendation shouldn’t be challenged. As a result, important questions often go unasked, like:
Patient empowerment is often framed around access to information or digital tools, and for good reason. But while these are important factors, one of its most overlooked elements is much simpler: permission to ask questions.
Digestive symptoms like bloating or nausea are often dismissed as “just part of being a woman.” Yet IBS is 2–6x more common in women, and chronic constipation is twice as prevalent. Recognizing gender-specific GI patterns is key to ensuring symptoms are taken seriously and properly treated.
In the latest Gut Matters episode, Dr. Andrea Shin and I speak with advocate Katherine Wald about navigating IBS-C alongside autoimmune and autonomic conditions. Her story highlights the toll of misdiagnosis and how listening and clinician partnership can truly change outcomes.
College can be a minefield for students with celiac disease, but the Celiac Disease Foundation just released the first national recommendations to guide colleges on housing, dining, academics, and campus life—helping students stay safe, supported, and included:
https://celiac.org/school-college/
No single diet fits all. Personalized, dietitian-led guidance—integrating symptoms, lifestyle, and metabolic factors—is key to balancing symptom control and long-term health.
> Precision diets (starch- and sucrose-reduced): Emerging options show promise, especially when tailored to genetic profiles, but require further validation.
> Mediterranean diet: A sustainable, holistic approach, emphasizing overall dietary quality and anti-inflammatory foods—good for long-term adherence.
> Gluten-free diet: Helpful for some, especially diarrhea-predominant IBS, but benefits often relate more to reduced fermentable carbs than gluten itself.
> Low-FODMAP diet (LFD): Strong evidence for short-term symptom relief, but requires careful supervision to avoid nutrient deficiencies or microbiome disruption.
> Traditional dietary advice: Simple, flexible, first-line guidance on regular meals, fiber, and hydration—safe, affordable, and effective for nearly half of patients.
Managing IBS is rarely straightforward. Diet often plays a central role, but with so many approaches, patients and clinicians can feel overwhelmed. A recent review in Nutrients highlights the key takeaways for dietary management:
Real-world health data hold huge potential for patient care, but remain fragmented and poorly governed. Treating them as public infrastructure with oversight and accountability could empower patients and advance research.
Video visits went from novelty to expectation in just a few years. Patients now want personalized, real-time care, and AI will push that further. Providers who think ahead and integrate tech thoughtfully will redefine the patient experience.
When symptoms overlap—oral ulcers, joint pain, GI inflammation—diagnosis isn’t always clear. But this recent case shows how early biopsy and multidisciplinary care prevented further complications and guided effective patient treatment.
The HUNT-GWAS study shows how genetics, including HLA-DQB1, can shape gut microbes like Agathobacter, potentially influencing celiac disease risk. It highlights the promise of integrating genomics and microbiome science to better understand disease and guide future precision medicine.
Social media offers support for people with celiac disease, but fear-driven content spreads fast. Balancing personal experience with credible advice helps patients manage gluten safely, with clinicians guiding them on how to use social media wisely.
GAHT in transgender adults with IBD didn’t raise overall flare risk, though flares were more common in those with active IBD at start or on testosterone. A great reminder that close monitoring is essential for patients' wellness and quality of life.
